Stock Insights : Adani Enterprises Ltd, Astral Ltd, Belrise Industries Ltd, BEML Ltd, Ceigall India Ltd, Infosys Ltd - ARETE Securities Ltd
The markets are expected to open marginally higher today as trends in GIFT NIFTY indicate a positive start for the broader index after NIFTY closed 221 points higher at 24,585 on Monday.
Adani Enterprises
The company’s step subsidiary Horizon Aero Solutions signed an agreement to acquire 100% stake in aircraft MRO firm Indamer Technics.
Astral
The company approved acquiring 80% in Nexelon Chem and investing up to Rs.120 crore to manufacture CPVC resin for cost optimisation and margin improvement.
Belrise Industries
The company approved incorporation of a wholly-owned subsidiary in India for defence, space, aerospace and allied engineering technologies business.
BEML
The company secured an order worth Rs.1,888 crore from Integral Coach Factory for manufacturing, supplying, testing and commissioning complete fully functional LHB coaches.
Ceigall India
The company emerged as L1 bidder for Rs.225 crore HPSIDC project to develop Bulk Drug Park infrastructure at Una, Himachal Pradesh.
Indian Hotels Company
The company will acquire 51% stakes in ANK Hotels and Pride Hospitality for up to Rs.110 crore and Rs.94 crore, expanding its midscale portfolio in India.
Indian Railway Finance Corporation
The company executed Rs.2,539 crore refinancing for Angul Sukinda Railway to enhance financial viability and support expansion of strategic freight corridor in Odisha.
Infosys
The company implemented the nCino Platform for ABN AMRO, unifying loan origination and collateral systems, migrating 100,000+ records to enhance efficiency and compliance.
Intellect Design Arena
The company launched IntellectAI’s Purple Fabric, the world’s first open business impact AI platform, in the U.S., targeting banks and insurers.
Larsen & Toubro
The company secured an ultra-mega Rs.15,000+ crore contract from Adani Power to set up 6,400MW thermal power capacity via CarbonLite Solutions.
Zydus Lifesciences
The company received USFDA final approval to market Diltiazem Hydrochloride Tablets in 30-120 mg strengths, with US sales of $13.9 million.
Please refer disclaimer at http://www.aretesecurities.com/
SEBI Regn. No.: INM0000127
